These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12350294)
1. Synthesis of glycosylated beta-amino acids as new class of antitubercular agents. Tripathi RP; Tripathi R; Tiwari VK; Bala L; Sinha S; Srivastava A; Srivastava R; Srivastava BS Eur J Med Chem; 2002 Sep; 37(9):773-81. PubMed ID: 12350294 [TBL] [Abstract][Full Text] [Related]
2. N1-Hetaryl substituted pyridine- and pyrazinecarboxamidrazones with antimycobacterial activity. Ranft D; Lehwark-Yvetot G; Schaper KJ; Büge A Arch Pharm (Weinheim); 1997 Jun; 330(6):169-72. PubMed ID: 9297448 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria. Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents. Küçükgüzel SG; Rollas S Farmaco; 2002 Jul; 57(7):583-7. PubMed ID: 12164219 [TBL] [Abstract][Full Text] [Related]
5. Effect of substituents on diarylmethanes for antitubercular activity. Panda G; Parai MK; Das SK; Shagufta ; Sinha M; Chaturvedi V; Srivastava AK; Manju YS; Gaikwad AN; Sinha S Eur J Med Chem; 2007 Mar; 42(3):410-9. PubMed ID: 17112639 [TBL] [Abstract][Full Text] [Related]
7. Antitubercular agents. Part 1: synthesis of phthalimido- and naphthalimido-linked phenazines as new prototype antitubercular agents. Kamal A; Hari Babu A; Venkata Ramana A; Sinha R; Yadav JS; Arora SK Bioorg Med Chem Lett; 2005 Apr; 15(7):1923-6. PubMed ID: 15780634 [TBL] [Abstract][Full Text] [Related]
8. In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria. Kaur D; Khuller GK Int J Antimicrob Agents; 2001 Jan; 17(1):51-5. PubMed ID: 11137649 [TBL] [Abstract][Full Text] [Related]
9. Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks? Malík I; Csöllei J; Solovič I; Pospíšilová Š; Michnová H; Jampílek J; Čížek A; Kapustíková I; Čurillová J; Pecháčová M; Stolaříková J; Pecher D; Oravec M Molecules; 2018 Sep; 23(10):. PubMed ID: 30274224 [TBL] [Abstract][Full Text] [Related]
10. Ethambutol-sugar hybrids as potential inhibitors of mycobacterial cell-wall biosynthesis. Reynolds RC; Bansal N; Rose J; Friedrich J; Suling WJ; Maddry JA Carbohydr Res; 1999 Apr; 317(1-4):164-79. PubMed ID: 10466213 [TBL] [Abstract][Full Text] [Related]
11. Substituted 4-methylquinolines as a new class of anti-tuberculosis agents. Jain R; Vaitilingam B; Nayyar A; Palde PB Bioorg Med Chem Lett; 2003 Mar; 13(6):1051-4. PubMed ID: 12643909 [TBL] [Abstract][Full Text] [Related]
12. Quinazoline derivatives with antitubercular activity. Kunes J; Bazant J; Pour M; Waisser K; Slosárek M; Janota J Farmaco; 2000; 55(11-12):725-9. PubMed ID: 11204949 [TBL] [Abstract][Full Text] [Related]
13. Fused 1,2-dithioles, V: Carbenoid anions as intermediates in reactions of pyrrothines and their heteroanalogues. Schachtner JE; Nienaber J; Stachel HD; Waisser K Pharmazie; 1999 May; 54(5):335-40. PubMed ID: 10368826 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives. Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F Farmaco; 1993 Apr; 48(4):529-38. PubMed ID: 8357468 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitubercular activity of 6-chloro (unsubstituted)- 2-methoxy-9-substituted acridine derivatives. Aly EI; Abadi AH Arch Pharm Res; 2004 Jul; 27(7):713-9. PubMed ID: 15356996 [TBL] [Abstract][Full Text] [Related]
16. New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents. Ancizu S; Moreno E; Solano B; Villar R; Burguete A; Torres E; Pérez-Silanes S; Aldana I; Monge A Bioorg Med Chem; 2010 Apr; 18(7):2713-9. PubMed ID: 20233660 [TBL] [Abstract][Full Text] [Related]
17. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria]. Zerbini E; Andreu D; Tonarelli G; Sequeira MD Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578 [TBL] [Abstract][Full Text] [Related]
18. The oriented development of antituberculotics: salicylanilides. Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291 [TBL] [Abstract][Full Text] [Related]
19. Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum. Guillemin I; Sougakoff W; Cambau E; Revel-Viravau V; Moreau N; Jarlier V Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2527-2532. PubMed ID: 10517605 [TBL] [Abstract][Full Text] [Related]